Middleton & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $208K | Hold |
2,900
| – | – | 0.02% | 161 |
|
|
2025
Q4 | $230K | Hold |
2,900
| – | – | 0.02% | 155 |
|
|
2025
Q3 | $219K | Sell |
2,900
-200
| -6% | -$13.7K | 0.02% | 161 |
|
|
2025
Q2 | $214K | Sell |
3,100
-400
| -11% | -$26.2K | 0.02% | 157 |
|
|
2025
Q1 | $237K | Sell |
3,500
-1,200
| -26% | -$71.8K | 0.03% | 145 |
|
|
2024
Q4 | $211K | Hold |
4,700
| – | – | 0.02% | 154 |
|
|
2024
Q3 | $296K | Hold |
4,700
| – | – | 0.03% | 139 |
|
|
2024
Q2 | $278K | Hold |
4,700
| – | – | 0.03% | 140 |
|
|
2024
Q1 | $375K | Sell |
4,700
-275
| -6% | -$21K | 0.04% | 132 |
|
|
2023
Q4 | $393K | Hold |
4,975
| – | – | 0.05% | 121 |
|
|
2023
Q3 | $347K | Sell |
4,975
-3,420
| -41% | -$242K | 0.05% | 120 |
|
|
2023
Q2 | $580K | Sell |
8,395
-630
| -7% | -$44.8K | 0.08% | 98 |
|
|
2023
Q1 | $671K | Sell |
9,025
-5,368
| -37% | -$450K | 0.1% | 96 |
|
|
2022
Q4 | $1.34M | Sell |
14,393
-350
| -2% | -$33.8K | 0.2% | 85 |
|
|
2022
Q3 | $1.41M | Sell |
14,743
-210
| -1% | -$20.8K | 0.21% | 78 |
|
|
2022
Q2 | $1.39M | Sell |
14,953
-479
| -3% | -$46.7K | 0.18% | 88 |
|
|
2022
Q1 | $1.56M | Sell |
15,432
-1,995
| -11% | -$210K | 0.17% | 88 |
|
|
2021
Q4 | $1.8M | Sell |
17,427
-455
| -3% | -$42K | 0.18% | 88 |
|
|
2021
Q3 | $1.52M | Sell |
17,882
-3,627
| -17% | -$304K | 0.16% | 89 |
|
|
2021
Q2 | $1.79M | Sell |
21,509
-93
| -0.4% | -$7.62K | 0.19% | 82 |
|
|
2021
Q1 | $1.63M | Sell |
21,602
-4,407
| -17% | -$321K | 0.18% | 85 |
|
|
2020
Q4 | $1.78M | Sell |
26,009
-3,748
| -13% | -$244K | 0.21% | 82 |
|
|
2020
Q3 | $1.74M | Sell |
29,757
-3,035
| -9% | -$189K | 0.23% | 76 |
|
|
2020
Q2 | $2.13M | Sell |
32,792
-6,490
| -17% | -$409K | 0.31% | 74 |
|
|
2020
Q1 | $2.33M | Buy |
39,282
+4,300
| +12% | +$287K | 0.41% | 61 |
|
|
2019
Q4 | $2.6M | Sell |
34,982
-2,480
| -7% | -$174K | 0.37% | 68 |
|
|
2019
Q3 | $2.36M | Sell |
37,462
-558
| -1% | -$33.1K | 0.36% | 69 |
|
|
2019
Q2 | $2.07M | Sell |
38,020
-3,711
| -9% | -$200K | 0.32% | 68 |
|
|
2019
Q1 | $2.25M | Buy |
41,731
+16,125
| +63% | +$995K | 0.36% | 67 |
|
|
2018
Q4 | $1.68M | Sell |
25,606
-1,778
| -6% | -$133K | 0.31% | 71 |
|
|
2018
Q3 | $2.16M | Sell |
27,384
-1,330
| -5% | -$95.1K | 0.34% | 71 |
|
|
2018
Q2 | $1.85M | Buy |
28,714
+61
| +0.2% | +$4.02K | 0.32% | 75 |
|
|
2018
Q1 | $1.78M | Sell |
28,653
-1,102
| -4% | -$79.1K | 0.32% | 75 |
|
|
2017
Q4 | $2.16M | Sell |
29,755
-57,856
| -66% | -$4.21M | 0.36% | 72 |
|
|
2017
Q3 | $7.12M | Buy |
87,611
+10,265
| +13% | +$812K | 1.29% | 28 |
|
|
2017
Q2 | $6.22M | Buy |
77,346
+14,780
| +24% | +$1.17M | 1.33% | 28 |
|
|
2017
Q1 | $4.91M | Sell |
62,566
-21,432
| -26% | -$1.71M | 1.08% | 35 |
|
|
2016
Q4 | $6.63M | Sell |
83,998
-20,183
| -19% | -$1.63M | 1.5% | 21 |
|
|
2016
Q3 | $9.27M | Buy |
104,181
+5,893
| +6% | +$556K | 2.08% | 12 |
|
|
2016
Q2 | $9.41M | Buy |
98,288
+5,109
| +5% | +$509K | 2.16% | 11 |
|
|
2016
Q1 | $9.66M | Buy |
93,179
+14,030
| +18% | +$1.36M | 2.24% | 11 |
|
|
2015
Q4 | $7.74M | Buy |
79,149
+34,513
| +77% | +$3.38M | 1.73% | 22 |
|
|
2015
Q3 | $4.31M | Buy |
44,636
+3,330
| +8% | +$350K | 1.02% | 37 |
|
|
2015
Q2 | $4.33M | Buy |
41,306
+2,912
| +8% | +$298K | 0.94% | 41 |
|
|
2015
Q1 | $3.96M | Buy |
38,394
+1,800
| +5% | +$182K | 0.87% | 43 |
|
|
2014
Q4 | $3.52M | Buy |
36,594
+966
| +3% | +$85.1K | 0.79% | 45 |
|
|
2014
Q3 | $2.84M | Buy |
35,628
+1,779
| +5% | +$140K | 0.67% | 48 |
|
|
2014
Q2 | $2.55M | Buy |
33,849
+860
| +3% | +$65K | 0.58% | 53 |
|
|
2014
Q1 | $2.47M | Buy |
32,989
+15,370
| +87% | +$1.09M | 0.58% | 56 |
|
|
2013
Q4 | $1.26M | Buy |
17,619
+4,260
| +32% | +$274K | 0.33% | 64 |
|
|
2013
Q3 | $758K | Sell |
13,359
-50
| -0.4% | -$2.98K | 0.2% | 88 |
|
|
2013
Q2 | $767K | Buy |
+13,409
| New | +$777K | 0.23% | 82 |
|
Other funds holding CVS
VCM
VPM
Middleton & Co's CVS Position: Q1 2026 in Review
Middleton & Co held its CVS Health (CVS) position steady in Q1 2026 at 2,900 shares worth $208K. The position accounts for 0.02% of the portfolio, ranked #161.
Middleton & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.66M in Q1 2016. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Middleton & Co held 2,900 shares of CVS Health worth $208K as of Q1 2026.
- Middleton & Co left its CVS Health share count unchanged in Q1 2026.
- CVS Health made up 0.02% of Middleton & Co's portfolio in Q1 2026, its #161 holding.
- Middleton & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Middleton & Co's CVS Health position peaked at $9.66M in Q1 2016.
- 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.